Ryan M. Thomas, Chief Executive Officer, Eyam

Ryan M. Thomas, an entrepreneur and trusted leader, with a passion for innovation in healthcare, is the co-founder, CEO, and a Director of the Board at Eyam Vaccines and Immunotherapeutics. Collaborating closely with Dr. Wilf Jefferies, Ryan is at the forefront of next generation vaccine and therapeutic technologies. His pivotal role in building a dynamic team and charting Eyam’s strategic course has been central to the development of its pioneering technologies. Possessing a global perspective honed by extensive experience across Latin America, Europe, and North America, Ryan’s expertise spans a diverse array of fields including finance, fundraising, and strategic advisory for nascent ventures. 

Ryan’s academic journey in Economics and Finance began at Regis University and was further refined through the Fund for American Studies at Georgetown University. His dedication to continuous learning led him to the prestigious Advanced Management Program at IESE Business School in Barcelona. At Eyam, Ryan melds his global experience, financial acumen, and strategic insight to tackle pressing biotechnological challenges. Under his leadership, Eyam has embarked on creating impactful solutions for the next-generation of vaccine and immunotherapeutic technologies.